Drugs Made In America Acquisition II Corp. Unit (DMIIU) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 4Aug 7Aug 12Aug 17Aug 20Aug 25Aug 28Sep 3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$712.83M

MomentumView details →

1D Return

+0.49%

YTD Return

+2.30%

RSI (14)

86.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$712.83M

RSI (14)

86.0

MomentumView details →

1D Return

+0.49%

YTD Return

+2.30%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for DMIIU.

Similar companies

Direxion Daily MSFT Bull 2X SharesMSFU New Mountain Finance CorporationNMFC Nomura Mid Cap Income Opportunities Fund;YIVOYX OFS Credit Company, Inc.OCCIN PennantPark Floating Rate Capital Ltd.PFLT Shanghai Realway Capital Assets Management Co., Ltd.01835.HK Find similar companies →

Latest newsMore news →

No recent news for DMIIU.